Related references
Note: Only part of the references are listed.Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine
Hadi Hassannia et al.
IMMUNOLOGY (2020)
Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy
Meng Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer
Romualdo Barroso-Sousa et al.
CLINICAL CANCER RESEARCH (2020)
Results of a Randomized Phase IIb Trial of Nelipepimut-S thorn Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer
G. Travis Clifton et al.
CLINICAL CANCER RESEARCH (2020)
Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway
Hui Zhong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Folate-conjugated herpes simplex virus for retargeting to tumor cells
Zhi-Qiang Ye et al.
JOURNAL OF GENE MEDICINE (2020)
Antimesothelioma Immunotherapy by CTLA-4 Blockade Depends on Active PD1-Based TWIST1 Vaccination
Zhiwu Tan et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Statin Drugs Plus Th1 Cytokines Potentiate Apoptosis and Ras Delocalization in Human Breast Cancer Lines and Combine with Dendritic Cell-Based Immunotherapy to Suppress Tumor Growth in a Mouse Model of HER-2pos Disease
Crystal M. Oechsle et al.
VACCINES (2020)
Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice
Bhagelu R. Achyut et al.
CANCER LETTERS (2020)
Endothelial heterogeneity across distinct vascular beds during homeostasis and inflammation
Ankit Jambusaria et al.
ELIFE (2020)
High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas
Ping Mei et al.
DIAGNOSTIC PATHOLOGY (2020)
LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models
Weidong Xu et al.
HUMAN GENE THERAPY (2020)
Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model
Shyambabu Chaurasiya et al.
ONCOIMMUNOLOGY (2020)
Overexpression of microRNA-155 enhances the efficacy of dendritic cell vaccine against breast cancer
Johnie Hodge et al.
ONCOIMMUNOLOGY (2020)
Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice
Bingfeng Zuo et al.
NATURE COMMUNICATIONS (2020)
Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer
Yann Kieffer et al.
CANCER DISCOVERY (2020)
Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment
Tao Shi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Dendritic Cells and Their Role in Immunotherapy
Alycia Gardner et al.
FRONTIERS IN IMMUNOLOGY (2020)
Oncolytic vesicular stomatitis virus-based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8+ T-cell functionality
Seyedeh-Raheleh Niavarani et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
Junyun Lai et al.
NATURE IMMUNOLOGY (2020)
Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis
Shanawaz M. Ghouse et al.
FRONTIERS IN ONCOLOGY (2020)
Are we ready to use TMB in breast cancer clinical practice?
Sara Ravaioli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
Josep Garcia et al.
CANCER TREATMENT REVIEWS (2020)
Investigation of the combination of anti-PD-L1 mAb with HER2/neu-loaded dendritic cells and QS-21 saponin adjuvant: effect against HER2 positive breast cancer in mice
Cenk Serhan Ozverel et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2020)
In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2
Weilin Liu et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models
Zhuangwei Lv et al.
ONCOIMMUNOLOGY (2020)
Doxorubicin pretreatment enhances FAPα/survivin co-targeting DNA vaccine anti-tumor activity primarily through decreasing peripheral MDSCs in the 4T1 murine breast cancer model
Fei Geng et al.
ONCOIMMUNOLOGY (2020)
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer
Yingxue Ren et al.
ONCOIMMUNOLOGY (2020)
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model
Huiqiang Zhao et al.
HUMAN GENE THERAPY (2019)
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers
V. Chung et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer
Qiuli Wang et al.
CURRENT GENE THERAPY (2019)
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966
Tae Jin Lee et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines
Juraimi Raihan et al.
BMC CANCER (2019)
Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach
Belen P. Solans et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Combination of Human Umbilical Vein Endothelial Cell Vaccine and Docetaxel Generates Synergistic Anti-Breast Cancer Effects
Meiyu Lu et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2019)
Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial
Elizabeth A. Mittendorf et al.
CLINICAL CANCER RESEARCH (2019)
Initial safety analysis of a randomized phase II trial of nelipepimut-S plus GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors
G. Travis Clifton et al.
CLINICAL IMMUNOLOGY (2019)
Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
Iris Koske et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
Linda Hammerich et al.
NATURE MEDICINE (2019)
Utilizing VEGF165b mutant as an effective immunization adjunct to augment antitumor immune response
Zhang Huiyong et al.
VACCINE (2019)
Toll-like receptor 3 acts as a suppressor gene in breast cancer initiation and progression: a two-stage association study and functional investigation
Lei Fan et al.
ONCOIMMUNOLOGY (2019)
Interplay Between LOX Enzymes and Integrins in the Tumor Microenvironment
Pier Giorgio Amendola et al.
CANCERS (2019)
Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells
Shengmeng Di et al.
FRONTIERS IN ONCOLOGY (2019)
Inhibition of breast cancer cells by targeting E2F-1 gene and expressing IL15 oncolytic adenovirus
Yang Yan et al.
BIOSCIENCE REPORTS (2019)
Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis
Wenfa Huang et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
A DNA vaccine expressing an optimized secreted FAPα induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer
Fei Geng et al.
VACCINE (2019)
Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells
Chen-Jei Tai et al.
SCIENTIFIC REPORTS (2019)
Cowpea Mosaic Virus Immunotherapy Combined with Cyclophosphamide Reduces Breast Cancer Tumor Burden and Inhibits Lung Metastasis
Hui Cai et al.
ADVANCED SCIENCE (2019)
Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results
Beatris Mastelic-Gavillet et al.
FRONTIERS IN IMMUNOLOGY (2019)
Recombinant virus-like particles presenting IL-33 successfully modify the tumor microenvironment and facilitate antitumor immunity in a model of breast cancer
Xuejun Feng et al.
ACTA BIOMATERIALIA (2019)
Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase Inhibitors
Roxana M. Rodriguez Stewart et al.
JOURNAL OF VIROLOGY (2019)
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
Krithika N. Kodumudi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Pre-surgical oncolytic virotherapy improves breast cancer outcomes
Victor Mullins-Dansereau et al.
ONCOIMMUNOLOGY (2019)
Role of the Microenvironment in Regulating Normal and Cancer Stem Cell Activity: Implications for Breast Cancer Progression and Therapy Response
Vasudeva Bhat et al.
CANCERS (2019)
The Immune Microenvironment of Breast Cancer Progression
Helen Tower et al.
CANCERS (2019)
B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer
Daniel P. Hollern et al.
CELL (2019)
The in vivo endothelial cell translatome is highly heterogeneous across vascular beds
Audrey C. A. Cleuren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Evaluation of a Recombinant Newcastle Disease Virus Expressing Human IL12 against Human Breast Cancer
Zahiah Mohamed Amin et al.
SCIENTIFIC REPORTS (2019)
Immunotherapy: A Challenge of Breast Cancer Treatment
Marilina Garcia-Aranda et al.
CANCERS (2019)
Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer
Wen Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade
Hong Jae Chon et al.
CLINICAL CANCER RESEARCH (2019)
microRNA modified tumor-derived exosomes as novel tools for maturation of dendritic cells
Adeleh Taghikhani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The functional role of integrins during intra- and extravasation within the metastatic cascade
Greta Soekeland et al.
MOLECULAR CANCER (2019)
Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib
Loral E. Showalter et al.
PLOS ONE (2019)
A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2+ breast cancer
Ricardo Costa et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
A CD40 Agonist and PD-1 Antagonist Antibody Reprogram the Microenvironment of Nonimmunogenic Tumors to Allow T-cell-Mediated Anticancer Activity
Hayley S. Ma et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells
Julia Krombach et al.
ONCOIMMUNOLOGY (2019)
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Combination of Oncolytic Measles Virus Armed With BNiP3, a Pro-apoptotic Gene and Paclitaxel Induces Breast Cancer Cell Death
Geetanjali Lal et al.
FRONTIERS IN ONCOLOGY (2019)
Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer
Eleni-Kyriaki Vetsika et al.
CELLS (2019)
Autologous hybrid cell fusion vaccine in a spontaneous intermediate model of breast carcinoma
R. Curtis Bird et al.
JOURNAL OF VETERINARY SCIENCE (2019)
Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response
Atefeh Arab et al.
IMMUNOLOGIC RESEARCH (2018)
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
M. E. Rodriguez-Ruiz et al.
ANNALS OF ONCOLOGY (2018)
PD1 protein expression in tumor infiltrated lymphocytes rather than PDL1 in tumor cells predicts survival in triple-negative breast cancer
Xinyu Ren et al.
CANCER BIOLOGY & THERAPY (2018)
TIM-3 Regulates CD103(+) Dendritic Cell Function and Response to Chemotherapy in Breast Cancer
Alvaro de Mingo Pulido et al.
CANCER CELL (2018)
Senescent cells re-engineered to express soluble programmed death receptor-1 for inhibiting programmed death receptor-1/programmed death ligand-1 as a vaccination approach against breast cancer
Zehong Chen et al.
CANCER SCIENCE (2018)
Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients
Kimberly R. Kalli et al.
CLINICAL CANCER RESEARCH (2018)
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
Lina Liu et al.
MOLECULAR THERAPY (2018)
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas et al.
NATURE MEDICINE (2018)
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple- negative breast cancer to immune checkpoint therapy
Marie-Claude Bourgeois-Daigneault et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice
Yufeng Xie et al.
VACCINE (2018)
A novel potential effective strategy for enhancing the antitumor immune response in breast cancer patients using a viable cancer cell-dendritic cell-based vaccine
Mona S. Abdellateif et al.
ONCOLOGY LETTERS (2018)
Antitumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro
Mi Tang et al.
ONCOLOGY LETTERS (2018)
A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer
Hatem Soliman et al.
Oncotarget (2018)
Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs
Julie M. Diamond et al.
CANCER IMMUNOLOGY RESEARCH (2018)
SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Acticates CD4+ T Lymphocytes
Markus D. Lacher et al.
FRONTIERS IN IMMUNOLOGY (2018)
M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine
Karin M. Knudson et al.
ONCOIMMUNOLOGY (2018)
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors
S. Feola et al.
ONCOIMMUNOLOGY (2018)
Endogenous Akt Activity Promotes Virus Entry and Predicts Efficacy of Novel Chimeric Orthopoxvirus in Triple-Negative Breast Cancer
Audrey H. Choi et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
Ibrahim Ragab Eissa et al.
CANCERS (2018)
ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
Sushil Kumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into CheckpointResponsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
Brian J. Christmas et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
Hanne Locy et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer
Adil Allahverdiyev et al.
JOURNAL OF BREAST CANCER (2018)
CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8(+) T Cells
Fernando P. Canale et al.
CANCER RESEARCH (2018)
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial
Lea Lowenfeld et al.
CLINICAL CANCER RESEARCH (2017)
Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma
Qiu Xia et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2017)
TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration
Anthony L. Schwartz et al.
ONCOTARGET (2017)
Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model
Dong Jin et al.
IMMUNOTHERAPY (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth
Paul D. Bryson et al.
VACCINE (2017)
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Woosung Chung et al.
NATURE COMMUNICATIONS (2017)
CTLA-4 positive breast cancer cells suppress dendritic cells maturation and function
Xi Chen et al.
ONCOTARGET (2017)
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
Jeremy B. Foote et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Evaluation of a xenogeneic vascular endothelial growth factor-2 vaccine in two preclinical metastatic tumor models in mice
Sofie Denies et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Therapeutic blockade of Foxp3 in experimental breast cancer models
Mariela A. Moreno Ayala et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells
Victor A. Gall et al.
CANCER RESEARCH (2017)
Results of a Phase Ib Trial of Combination Immunotherapy with a CD8+T Cell Eliciting Vaccine and Trastuzumab in Breast Cancer Patients
G. Travis Clifton et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Immunogenicity of a Fully Synthetic MUC1 Glycopeptide Antitumor Vaccine Enhanced by Poly(I:C) as a TLR3-Activating Adjuvant
Markus Glaffig et al.
CHEMMEDCHEM (2017)
Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
Simona Bramante et al.
ONCOIMMUNOLOGY (2016)
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence
E. A. Mittendorf et al.
ANNALS OF ONCOLOGY (2016)
Anti-tumor effects of DNA vaccine targeting human fibroblast activation protein α by producing specific immune responses and altering tumor microenvironment in the 4T1 murine breast cancer model
Qiu Xia et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Low dose cyclophosphamide: Mechanisms of T cell modulation
Mutsa Tatenda Madondo et al.
CANCER TREATMENT REVIEWS (2016)
Localized signals that regulate transendothelial migration
William A. Muller
CURRENT OPINION IN IMMUNOLOGY (2016)
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Geoffrey T. Gibney et al.
LANCET ONCOLOGY (2016)
Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies
Dawei Shou et al.
ONCOTARGET (2016)
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Sasha E. Stanton et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer
Parvin Forghani et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?
Samuel C. Wagner et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Enhanced antitumor immunity of nanoliposome-encapsulated heat shock protein 70 peptide complex derived from dendritic tumor fusion cells
Yunfei Zhang et al.
ONCOLOGY REPORTS (2015)
Role of the Tumor Microenvironment in Breast Cancer
Savas D. Soysal et al.
PATHOBIOLOGY (2015)
T-cell exhaustion in the tumor microenvironment
Y. Jiang et al.
CELL DEATH & DISEASE (2015)
CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome
Yi Huang et al.
ONCOTARGET (2015)
NOTCH Decoys That Selectively Block DLL/NOTCH or JAG/NOTCH Disrupt Angiogenesis by Unique Mechanisms to Inhibit Tumor Growth
Thaned Kangsamaksin et al.
CANCER DISCOVERY (2015)
A GM-CSF and CD4OL bystander vaccine is effective in a murine breast cancer model
Hatem Soliman et al.
BREAST CANCER-TARGETS AND THERAPY (2015)
Association between CD8+T-cell infiltration and breast cancer survival in 12 439 patients
H. R. Ali et al.
ANNALS OF ONCOLOGY (2014)
Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody
Lavakumar Karyampudi et al.
CANCER RESEARCH (2014)
Transcriptional profile of fibroblasts obtained from the primary site, lymph node and bone marrow of breast cancer patients
Paulo Roberto Del Valle et al.
GENETICS AND MOLECULAR BIOLOGY (2014)
Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines
Benedetto Farsaci et al.
CANCER IMMUNOLOGY RESEARCH (2014)
A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF-Secreting Breast Tumor Vaccine for HER2+ Metastatic Breast Cancer
Gang Chen et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Pattern response of dendritic cells in the tumor microenvironment and breast cancer
Alessandra da Cunha et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Active immunotherapy for mouse breast cancer with irradiated whole-cell vaccine expressing VEGFR2
Heng-Xiu Yan et al.
ONCOLOGY REPORTS (2013)
Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery
Jarrod Predina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer
Touko Inao et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
Anupama Sharma et al.
CANCER (2012)
Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome
Yingzi Ge et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
Chun-Jian Qi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective
Dung T. Le et al.
CANCER RESEARCH (2012)
VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
Hailing Lu et al.
CLINICAL CANCER RESEARCH (2012)
Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination
Fabian Benencia et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Vaccines Targeting Tumor Blood Vessel Antigens Promote CD8+ T Cell-Dependent Tumor Eradication or Dormancy in HLA-A2 Transgenic Mice
Xi Zhao et al.
JOURNAL OF IMMUNOLOGY (2012)
CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
Andrew J. Rech et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models
Y. Liu et al.
CANCER GENE THERAPY (2011)
Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105
Laurence M. Wood et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
Soyoung Baek et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus, the TLR3 agonist poly(I:C)
Darin A. Wick et al.
VACCINE (2011)
Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells
Ofer Fainaru et al.
FASEB JOURNAL (2010)
Visualizing extravasation dynamics of metastatic tumor cells
Konstantin Stoletov et al.
JOURNAL OF CELL SCIENCE (2010)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial
Hakan Norell et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu
Prema P. Peethambaram et al.
CLINICAL CANCER RESEARCH (2009)
An Anti-Vascular Endothelial Growth Factor Receptor 2/Fetal Liver Kinase-1 Listeria monocytogenes Anti-Angiogenesis Cancer Vaccine for the Treatment of Primary and Metastatic Her-2/neu+ Breast Tumors in a Mouse Model
Matthew M. Seavey et al.
JOURNAL OF IMMUNOLOGY (2009)
Antibody association with HER-2/neu-targeted vaccine enhances CD8+ T cell responses in mice through Fc-mediated activation of DCs
Peter S. Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells
Baldev Vasir et al.
JOURNAL OF IMMUNOLOGY (2008)
Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development
Caroline Aspord et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Jeong M. Kim et al.
NATURE IMMUNOLOGY (2007)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer
Sung-Hyung Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
A novel DNA vaccine encoding PDGFRβ suppresses growth and dissemination of murine colon, lung and breast carcinoma
Charles D. Kaplan et al.
VACCINE (2006)
Prolongation of the survival of breast cancer-bearing mice immunized with GM-CSF-secreting syngeneic/allogeneic fibroblasts transfected with a cDNA expression library from breast cancer cells
Tae S. Kim et al.
VACCINE (2006)
A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer
Cari J. McDonald et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine
Matthew T. Hueman et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Immunity to breast cancer in mice immunized with fibroblasts transfected with a cDNA expression library derived from small numbers of breast cancer cells
TS Kim et al.
CANCER GENE THERAPY (2005)
Distinct epigenetic changes in the stromal cells of breast cancers
M Hu et al.
NATURE GENETICS (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency
A Gervais et al.
BREAST CANCER RESEARCH (2005)
Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains
AR Schenkel et al.
JOURNAL OF IMMUNOLOGY (2004)
Dendritic cell infiltration and prognosis of early stage breast cancer
I Treilleux et al.
CLINICAL CANCER RESEARCH (2004)
Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells
HM Pinedo et al.
EUROPEAN JOURNAL OF CANCER (2003)
Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor
Y Lu et al.
JOURNAL OF IMMUNOLOGY (2003)
Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability
TH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSF
C Gasparetto et al.
CYTOKINE (2002)
Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
YQ Wei et al.
NATURE MEDICINE (2000)
Share Paper
